ID   EPHA6_HUMAN             Reviewed;        1036 AA.
AC   Q9UF33; D6RAL5;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   14-MAY-2014, sequence version 3.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Ephrin type-A receptor 6;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 2;
DE            Short=EHK-2;
DE   AltName: Full=EPH-like kinase 12;
DE            Short=EK12;
DE   Flags: Precursor;
GN   Name=EPHA6; Synonyms=EHK2, HEK12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=14726470; DOI=10.1373/clinchem.2003.026849;
RA   Hafner C., Schmitz G., Meyer S., Bataille F., Hau P., Langmann T.,
RA   Dietmaier W., Landthaler M., Vogt T.;
RT   "Differential gene expression of Eph receptors and ephrins in benign
RT   human tissues and cancers.";
RL   Clin. Chem. 50:490-499(2004).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-704.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The
CC       heterotetramer is composed of an ephrin dimer and a receptor
CC       dimer. Oligomerization is probably required to induce biological
CC       responses (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UF33-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UF33-2; Sequence=VSP_018473, VSP_018474, VSP_018475,
CC                                  VSP_018476;
CC       Name=3;
CC         IsoId=Q9UF33-3; Sequence=VSP_018473, VSP_018474, VSP_054716,
CC                                  VSP_054717;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and testis.
CC       {ECO:0000269|PubMed:14726470}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133666; CAB63775.1; -; mRNA.
DR   EMBL; AC109782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC134730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135369; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS54616.1; -. [Q9UF33-2]
DR   CCDS; CCDS63697.1; -. [Q9UF33-3]
DR   PIR; T43450; T43450.
DR   RefSeq; NP_001265229.1; NM_001278300.1. [Q9UF33-3]
DR   RefSeq; NP_775926.1; NM_173655.3. [Q9UF33-2]
DR   UniGene; Hs.272208; -.
DR   UniGene; Hs.653244; -.
DR   ProteinModelPortal; Q9UF33; -.
DR   SMR; Q9UF33; -.
DR   BioGrid; 130049; 3.
DR   STRING; 9606.ENSP00000374323; -.
DR   BindingDB; Q9UF33; -.
DR   ChEMBL; CHEMBL4526; -.
DR   GuidetoPHARMACOLOGY; 1826; -.
DR   iPTMnet; Q9UF33; -.
DR   PhosphoSitePlus; Q9UF33; -.
DR   DMDM; 97048747; -.
DR   EPD; Q9UF33; -.
DR   PaxDb; Q9UF33; -.
DR   PeptideAtlas; Q9UF33; -.
DR   PRIDE; Q9UF33; -.
DR   DNASU; 285220; -.
DR   Ensembl; ENST00000502694; ENSP00000423950; ENSG00000080224. [Q9UF33-2]
DR   Ensembl; ENST00000514100; ENSP00000421711; ENSG00000080224. [Q9UF33-3]
DR   GeneID; 285220; -.
DR   KEGG; hsa:285220; -.
DR   UCSC; uc003drr.6; human. [Q9UF33-1]
DR   CTD; 285220; -.
DR   DisGeNET; 285220; -.
DR   GeneCards; EPHA6; -.
DR   HGNC; HGNC:19296; EPHA6.
DR   HPA; HPA007397; -.
DR   HPA; HPA058047; -.
DR   MIM; 600066; gene.
DR   neXtProt; NX_Q9UF33; -.
DR   OpenTargets; ENSG00000080224; -.
DR   PharmGKB; PA134866684; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOGENOM; HOG000233858; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q9UF33; -.
DR   KO; K05107; -.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q9UF33; -.
DR   SIGNOR; Q9UF33; -.
DR   ChiTaRS; EPHA6; human.
DR   GeneWiki; EPHA6; -.
DR   GenomeRNAi; 285220; -.
DR   PRO; PR:Q9UF33; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000080224; -.
DR   CleanEx; HS_EPHA6; -.
DR   ExpressionAtlas; Q9UF33; baseline and differential.
DR   Genevisible; Q9UF33; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   CDD; cd10484; EphR_LBD_A6; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034280; EphA6_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Complete proteome; Glycoprotein;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1036       Ephrin type-A receptor 6.
FT                                /FTId=PRO_0000235684.
FT   TOPO_DOM     23    550       Extracellular. {ECO:0000255}.
FT   TRANSMEM    551    571       Helical. {ECO:0000255}.
FT   TOPO_DOM    572   1036       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       34    212       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      331    441       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      442    537       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      631    944       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      961   1025       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     637    645       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF      1034   1036       PDZ-binding. {ECO:0000255}.
FT   ACT_SITE    798    798       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     663    663       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     606    606       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     612    612       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     831    831       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     978    978       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    410    410       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    514       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_018473.
FT   VAR_SEQ     515    538       IRVRTATGYSGYSQKFEFETGDET -> MKDSPFQVTKLYW
FT                                LNEKWDFIASA (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_018474.
FT   VAR_SEQ     835    912       GGKIPIRWTAPEAIAYRKFSSASDAWSYGIVMWEVMSYGER
FT                                PYWEMSNQDVILSIEEGYRLPAPMGCPASLHQLMLHC ->
FT                                RPTNHNKEQSELVKEDGLESLCEQCESSSGYGTGLVLMWKR
FT                                NRRAMGASGQTRKQCDKRDNPPTDLFQTLTLNLCYSA (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054716.
FT   VAR_SEQ     835    848       GGKIPIRWTAPEAI -> DLFQTLTLNLCYSA (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_018475.
FT   VAR_SEQ     849   1036       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_018476.
FT   VAR_SEQ     913   1036       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054717.
FT   VARIANT     704    704       F -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042149.
FT   VARIANT     711    711       A -> V (in dbSNP:rs4857276).
FT                                /FTId=VAR_055991.
SQ   SEQUENCE   1036 AA;  116379 MW;  53402C6DCD7CD32C CRC64;
     MGGCEVREFL LQFGFFLPLL TAWPGDCSHV SNNQVVLLDT TTVLGELGWK TYPLNGWDAI
     TEMDEHNRPI HTYQVCNVME PNQNNWLRTN WISRDAAQKI YVEMKFTLRD CNSIPWVLGT
     CKETFNLFYM ESDESHGIKF KPNQYTKIDT IAADESFTQM DLGDRILKLN TEIREVGPIE
     RKGFYLAFQD IGACIALVSV RVFYKKCPFT VRNLAMFPDT IPRVDSSSLV EVRGSCVKSA
     EERDTPKLYC GADGDWLVPL GRCICSTGYE EIEGSCHACR PGFYKAFAGN TKCSKCPPHS
     LTYMEATSVC QCEKGYFRAE KDPPSMACTR PPSAPRNVVF NINETALILE WSPPSDTGGR
     KDLTYSVICK KCGLDTSQCE DCGGGLRFIP RHTGLINNSV IVLDFVSHVN YTFEIEAMNG
     VSELSFSPKP FTAITVTTDQ DAPSLIGVVR KDWASQNSIA LSWQAPAFSN GAILDYEIKY
     YEKEHEQLTY SSTRSKAPSV IITGLKPATK YVFHIRVRTA TGYSGYSQKF EFETGDETSD
     MAAEQGQILV IATAAVGGFT LLVILTLFFL ITGRCQWYIK AKMKSEEKRR NHLQNGHLRF
     PGIKTYIDPD TYEDPSLAVH EFAKEIDPSR IRIERVIGAG EFGEVCSGRL KTPGKREIPV
     AIKTLKGGHM DRQRRDFLRE ASIMGQFDHP NIIRLEGVVT KRSFPAIGVE AFCPSFLRAG
     FLNSIQAPHP VPGGGSLPPR IPAGRPVMIV VEYMENGSLD SFLRKHDGHF TVIQLVGMLR
     GIASGMKYLS DMGYVHRDLA ARNILVNSNL VCKVSDFGLS RVLEDDPEAA YTTTGGKIPI
     RWTAPEAIAY RKFSSASDAW SYGIVMWEVM SYGERPYWEM SNQDVILSIE EGYRLPAPMG
     CPASLHQLML HCWQKERNHR PKFTDIVSFL DKLIRNPSAL HTLVEDILVM PESPGEVPEY
     PLFVTVGDWL DSIKMGQYKN NFVAAGFTTF DLISRMSIDD IRRIGVILIG HQRRIVSSIQ
     TLRLHMMHIQ EKGFHV
//
